PBMWW NASDAQ
Psyence Biomedical Ltd. Warrant
1W: -8.7%
1M: -10.6%
3M: +5.5%
YTD: +16.6%
1Y: -29.7%
$0.02
+0.00 (+0.48%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$46M
-1316.9% ▼
Net Income
-$51M
-1495.5% ▼
EPS (Diluted)
$0.00
+0.0% ▲
EBITDA
-$50M
-1451.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Gross Margin | — | — | — |
| R&D Expenses | $137K | $2M | $955K |
| SG&A Expenses | $2M | $2M | $2M |
| Operating Expenses | $2M | $3M | $47M |
| Operating Income | -$2M | -$3M | -$46M |
| Operating Margin | — | — | — |
| Interest Expense | $0 | $0 | $53K |
| Income Before Tax | -$2M | -$3M | -$51M |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$2M | -$3M | -$51M |
| Net Margin | — | — | — |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 |
| EBITDA | -$2M | -$3M | -$50M |
| Shares Outstanding | 0 | 0 | 0 |